NASDAQ
No price data available for this timeframe.
Celldex Therapeutics, Inc. (CLDX) has a price/sales ratio of 1204.09x as of Friday, May 22, 2026. This represents a 174.63% increase compared to its 12-month average of 438.44x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.